Logo image of ALBKK.PA

BAIKOWSKI SAS (ALBKK.PA) Stock Fundamental Analysis

EPA:ALBKK - Euronext Paris - Matif - FR0013384369 - Common Stock - Currency: EUR

21.2  +0.6 (+2.91%)

Fundamental Rating

5

ALBKK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. ALBKK has an excellent financial health rating, but there are some minor concerns on its profitability. ALBKK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year ALBKK was profitable.
ALBKK had a positive operating cash flow in the past year.
ALBKK had positive earnings in each of the past 5 years.
Each year in the past 5 years ALBKK had a positive operating cash flow.
ALBKK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBKK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

ALBKK's Return On Assets of 5.47% is fine compared to the rest of the industry. ALBKK outperforms 72.46% of its industry peers.
ALBKK has a better Return On Equity (8.28%) than 63.77% of its industry peers.
ALBKK has a Return On Invested Capital (3.85%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALBKK is below the industry average of 6.66%.
Industry RankSector Rank
ROA 5.47%
ROE 8.28%
ROIC 3.85%
ROA(3y)5.5%
ROA(5y)5.78%
ROE(3y)8.43%
ROE(5y)9.14%
ROIC(3y)4.4%
ROIC(5y)4.46%
ALBKK.PA Yearly ROA, ROE, ROICALBKK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 7.95%, ALBKK is doing good in the industry, outperforming 73.91% of the companies in the same industry.
In the last couple of years the Profit Margin of ALBKK has grown nicely.
ALBKK has a Operating Margin of 6.12%. This is comparable to the rest of the industry: ALBKK outperforms 57.97% of its industry peers.
ALBKK's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 58.07%, ALBKK belongs to the top of the industry, outperforming 88.41% of the companies in the same industry.
ALBKK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.12%
PM (TTM) 7.95%
GM 58.07%
OM growth 3Y-22.94%
OM growth 5Y-0.34%
PM growth 3Y-19.29%
PM growth 5Y4.18%
GM growth 3Y-5.48%
GM growth 5Y-1.45%
ALBKK.PA Yearly Profit, Operating, Gross MarginsALBKK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALBKK is destroying value.
Compared to 1 year ago, ALBKK has about the same amount of shares outstanding.
The number of shares outstanding for ALBKK remains at a similar level compared to 5 years ago.
The debt/assets ratio for ALBKK has been reduced compared to a year ago.
ALBKK.PA Yearly Shares OutstandingALBKK.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALBKK.PA Yearly Total Debt VS Total AssetsALBKK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALBKK has an Altman-Z score of 3.93. This indicates that ALBKK is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ALBKK (3.93) is better than 76.81% of its industry peers.
ALBKK has a debt to FCF ratio of 5.76. This is a neutral value as ALBKK would need 5.76 years to pay back of all of its debts.
ALBKK has a Debt to FCF ratio of 5.76. This is in the better half of the industry: ALBKK outperforms 68.12% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that ALBKK is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.18, ALBKK is doing good in the industry, outperforming 75.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.76
Altman-Z 3.93
ROIC/WACC0.55
WACC7.02%
ALBKK.PA Yearly LT Debt VS Equity VS FCFALBKK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALBKK has a Current Ratio of 2.23. This indicates that ALBKK is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.23, ALBKK is doing good in the industry, outperforming 72.46% of the companies in the same industry.
ALBKK has a Quick Ratio of 1.24. This is a normal value and indicates that ALBKK is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.24, ALBKK is doing good in the industry, outperforming 62.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.24
ALBKK.PA Yearly Current Assets VS Current LiabilitesALBKK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

ALBKK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 313.58%, which is quite impressive.
Measured over the past 5 years, ALBKK shows a small growth in Earnings Per Share. The EPS has been growing by 7.64% on average per year.
The Revenue has grown by 32.61% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 3.34% on average over the past years.
EPS 1Y (TTM)313.58%
EPS 3Y-17.66%
EPS 5Y7.64%
EPS Q2Q%207.77%
Revenue 1Y (TTM)32.61%
Revenue growth 3Y2.06%
Revenue growth 5Y3.34%
Sales Q2Q%66.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBKK.PA Yearly Revenue VS EstimatesALBKK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.58 indicates a rather expensive valuation of ALBKK.
ALBKK's Price/Earnings ratio is a bit cheaper when compared to the industry. ALBKK is cheaper than 60.87% of the companies in the same industry.
ALBKK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.32.
Industry RankSector Rank
PE 20.58
Fwd PE N/A
ALBKK.PA Price Earnings VS Forward Price EarningsALBKK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALBKK is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALBKK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 33.57
EV/EBITDA 12.97
ALBKK.PA Per share dataALBKK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

ALBKK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.69
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

ALBKK has a Yearly Dividend Yield of 1.29%.
ALBKK's Dividend Yield is comparable with the industry average which is at 3.00.
With a Dividend Yield of 1.29, ALBKK pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALBKK.PA Yearly Dividends per shareALBKK.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ALBKK.PA Yearly Income VS Free CF VS DividendALBKK.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

More info and screens

BAIKOWSKI SAS

EPA:ALBKK (6/17/2025, 7:00:00 PM)

21.2

+0.6 (+2.91%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.15%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap78.02M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.58
Fwd PE N/A
P/S 1.64
P/FCF 33.57
P/OCF 11.91
P/B 1.7
P/tB 1.98
EV/EBITDA 12.97
EPS(TTM)1.03
EY4.86%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.63
FCFY2.98%
OCF(TTM)1.78
OCFY8.4%
SpS12.96
BVpS12.44
TBVpS10.7
PEG (NY)N/A
PEG (5Y)2.69
Profitability
Industry RankSector Rank
ROA 5.47%
ROE 8.28%
ROCE 5.24%
ROIC 3.85%
ROICexc 4.28%
ROICexgc 4.9%
OM 6.12%
PM (TTM) 7.95%
GM 58.07%
FCFM 4.87%
ROA(3y)5.5%
ROA(5y)5.78%
ROE(3y)8.43%
ROE(5y)9.14%
ROIC(3y)4.4%
ROIC(5y)4.46%
ROICexc(3y)5.21%
ROICexc(5y)5.32%
ROICexgc(3y)6.11%
ROICexgc(5y)6.27%
ROCE(3y)5.99%
ROCE(5y)6.08%
ROICexcg growth 3Y-24.8%
ROICexcg growth 5Y2.36%
ROICexc growth 3Y-24.04%
ROICexc growth 5Y2.87%
OM growth 3Y-22.94%
OM growth 5Y-0.34%
PM growth 3Y-19.29%
PM growth 5Y4.18%
GM growth 3Y-5.48%
GM growth 5Y-1.45%
F-Score6
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.76
Debt/EBITDA 1.27
Cap/Depr 114.24%
Cap/Sales 8.87%
Interest Coverage 7.08
Cash Conversion 99.02%
Profit Quality 61.34%
Current Ratio 2.23
Quick Ratio 1.24
Altman-Z 3.93
F-Score6
WACC7.02%
ROIC/WACC0.55
Cap/Depr(3y)92.13%
Cap/Depr(5y)70.79%
Cap/Sales(3y)7.58%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)313.58%
EPS 3Y-17.66%
EPS 5Y7.64%
EPS Q2Q%207.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.61%
Revenue growth 3Y2.06%
Revenue growth 5Y3.34%
Sales Q2Q%66.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9306.45%
EBIT growth 3Y-21.36%
EBIT growth 5Y2.99%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y196.59%
FCF growth 3Y-35.63%
FCF growth 5YN/A
OCF growth 1Y735.71%
OCF growth 3Y-14.23%
OCF growth 5Y51.06%